Wrapping up CPhI Worldwide 2022 in Frankfurt, Germany
EMBO CAPS® has finished another year of CPhI Worldwide in Frankfurt this year. Successfully delivering solutions to current market issues, EMBO CAPS® has engaged in high quality networking.
As the Benchmark of Quality and to support the growing vegan population, EMBO CAPS® has been introducing wide range of HPMC capsules (non-animal origin) as the VG Collection. EMBO CAPS® HPMC capsules consist of EMBO CAPS® VG Pro, EMBO CAPS® Alpha, and EMBO CAPS® AP. Market has higher demand for EMBO CAPS® AP (Acid protection), which is well suitable for encapsulating probiotics and enzymes. EMBO CAPS® is one of the few suppliers that can offer delayed release hard capsules.
Takeaways from this event would be the importance of a reliable supplier. Not only talking about the capsule availability, a reliable supplier should be able to offer innovative products in accordance to the changing regulations. EMBO CAPS® presented full set of Aurora capsules - wide range of natural colors without using titanium dioxide. With the possibility of titanium dioxide ban in Europe for the pharmaceutical industry, EMBO CAPS® was also prepared various alternatives.
Contact firstname.lastname@example.org or your EMBOCAPS representatives for further information.
- PrevEMBO CAPS® receives Korea ESG rating for 2022 22.11.28
- NextEMBO CAPS® has been awarded with EcoVadis Bronze Medal (2022) 22.10.25